Abstract
Formerly considered to serve only as structural components, sphingolipids are emerging as an important group of signaling molecules involved in many cellular events, including cell growth, senescence, meiotic maturation, and cell death. They are also implicated in functions such as inflammation and the responses to heat shock and genotoxic stress. Defects in the metabolism of sphingolipids are related to various genetic disorders, and sphingolipids have the potential to serve as therapeutic agents for human diseases such as colon cancer and viral or bacterial infections. The best-studied member of this family, ceramide, which also serves as the structural back-bone for other sphingolipids, is an important mediator in multiple cellular signaling pathways. The metabolism and functions of sphingolipids are discussed in this review, with a focus on ceramide regulation in various cellular responses.
Similar content being viewed by others
References
Horejsi, V., Drbal, K., Cebecauer, M., Cerny, J., Brdicka, T., Angelisova, P., et al. (1999) GPI-microdomains: a role in signalling via immunoreceptors. Immunol. Today 20, 356–361.
Cremesti, A. E., Goni, F. M., and Kolesnick, R. (2002) Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?. FEBS Lett. 531, 47–53.
Hannun, Y. A. Sphingolipid-Mediated Signal Transduction. R. G. Landes Company, Austin, TX, 1997.
Merrill, A. H., Jr., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J. et al. (1997) Sphingolipids—the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol. Applied Pharmacol. 142, 208–225.
Prieschl, E. E. and Baumruker, T. (2000) Sphingolipids: second messengers, mediators and raft constituents in signaling. Immunol. Today 21, 555–560.
Ohanian, J. and Ohanian, V. (2001) Sphingolipids in mammalian cell signalling. Cell Mol. Life Sci. 58, 2053–2068.
Jarvis, W. D. and Grant, S. (1998) The role of ceramide in the cellular response to cytotoxic agents. Curr. Opin. Oncol. 10, 552–559.
Dbaibo, G. S. (1997) Regulation of the stress response by ceramide. Biochem. Soc. Trans. 25, 557–561.
Yang, J. and Duerksen-Hughes, P. J. (2001) Activation of a p53-independent, sphingolipid-mediated cytolytic pathway in p53-negative mouse fibroblast cells treated with N-methyl-N-nitro-N-nitrosoguanidine. J. Biol. Chem. 276, 27129–27135.
Luberto, C., Hassler, D. F., Signorelli, P., Okamoto, Y., Sawai, H., Boros, E., et al. (2002) Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J. Biol. Chem. 277, 41128–41139.
Colell, A., Morales, A., Fernandez-Checa, J. C., and Garcia-Ruiz, C. (2002) Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-alpha-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3. FEBS Lett. 526, 135–141.
Pru, J. K., Hendry, I. R., Davis, J. S., and Rueda, B. R. (2002) Soluble Fas ligand activates the sphingomyelin pathway and induces apoptosis in luteal steroidogenic cells independently of stress-activated p38(MAPK). Endocrinology 143, 4350–4357.
Geilen, C. C., Barz, S., and Bektas, M. (2001) Sphingolipid signaling in epidermal homeostasis. Current knowledge and new therapeutic approaches in dermatology. Skin Pharmacol. Appl. Skin Physiol. 14, 261–271.
Olivera, A. and Spiegel, S. (1993) Sphingosine-1-phosphate as a second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365, 557–560.
Olivera, A., Zhang, H., Carlson, R.O., Mattie, M.E., Schmidt, R.R. and Spiegel, S. (1994) Stereospecificity of sphingosine-induced intra-cellular calcium mobilization and cellular proliferation. J. Biol. Chem. 269, 17924–17930.
Davaille, J., Li, L., Mallat, A., and Lotersztajn, S. (2002) Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J. Biol. Chem. 277, 37323–37330.
Radin, N. S. (2002) The development of aggressive cancer: a possible role for sphingolipids. Cancer Invest. 20, 779–786.
Senchenkov, A., Litvak, D. A., and Cabot, M. C. (2001) Targeting ceramide metabolism—a strategy for overcoming drug resistance. J. Natl. Cancer Inst. 93, 347–357.
Sietsma, H., Veldman, R.J., and Kok, J. W. (2001) The involvement of sphingolipids in multidrug resistance. J. Membr. Biol. 181, 153–162.
Auge, N., Negre-Salvayre, A., Salvayre, R., and Levade, T. (2000) Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog. Lipid. Res. 39, 207–229.
Cutler, R. G. and Mattson, M. P. (2001) Sphingomyelin and ceramide as regulators of development and lifespan. Mech. Ageing Dev. 122, 895–908.
Wyrick, P. B. (2000) Intracellular survival by Chlamydia. Cell. Microbiol. 2, 275–282.
Raulin, J. (2002) Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapy. Prog. Lipid. Res. 41, 27–65.
van Ooij, C., Kalman, L., van Ijzendoorn, S., Nishijima, M., Hanada, K., Mostov, K., et al. (2000) Host cell-derived sphingolipids are required for the intracellular growth of Chlamydi trachomatis. Cell. Microbiol. 2, 627–637.
Schmelz, E. M., Bushnev, A. S., Dillehay, D. L., Liotta, D. C., and Merrill, A. H., Jr. (1997) Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones. Nutr. Cancer 28, 81–85.
Schmelz, E. M. and Merrill, A. H., Jr. (1998) Ceramides and ceramide metabolites in cell regulation: evidence for dietary sphingolipids as inhibitors of colon carcinogenesis. Nutrition 14, 717–719.
Schmelz, E. M., Sullards, M. C., Dillehay, D. L., and Merrill, A. H., Jr. (2000) Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice. J. Nutr. 130, 522–527.
Berra, B., Colombo, I., Sottocornola, E., and Giacosa, A. (2002) Dietary sphingolipids in colorectal cancer prevention. Eur. J. Cancer Prev. 11, 193–197.
Hannun, Y. A., Luberto, C., and Argraves, K. M. (2001) Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40, 4893–4903.
Ferlinz, K., Hurwitz, R., Vielhaber, G., Suzuki, K., and Sandhoff, K. (1994) Occurrence of two molecular forms of human acid sphingomyelianse. Biochem. J. 310, 855–862.
Ichikawa, S., Sakiyama, H., Suzuki, G., Hidari, K. I., and Hirabayashi, Y. (1996) Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc. Natl. Acad. Sci. USA 93, 4638–4643.
Bernardo, K., Hurwitz, R., Zenk, T., Desnick, R. J., Ferlinz, K., Schuchman, E. H., and Sandhoff, K. (1995) Purification, characterization, and biosynthesis of human acid ceramidase. J. Biol. Chem. 270, 11098–11102.
Yada, Y., Higuchi, K., and Imokawa, G. (1995) Purification and biochemical characterization of membrane-bound epidermal ceramidases from guinea pig skin. J. Biol. Chem. 270, 12677–12684.
Nikolova-Karakashian, M. and Merrill, A. H. Jr. (2000) Ceramidases. Methods Enzymol. 311, 194–201.
Hanada, K., Hara, T., and Nishijima, M. (2000) Purification of the serine palmitoyltransferase complex responsible for sphingoid base synthesis by using affinity peptide chromatography techniques. J. Biol. Chem. 275, 8409–8415.
Ternes, P., Franke, S., Zahringer, U., Sperling, P., and Heinz, E. (2002) Identification and characterization of a sphingolipid delta 4-desaturase family. J. Biol. Chem. 277, 25512–25518.
Liu, H., Chakravarty, D., Maceyka, M., Milstien, S., and Spiegel, S. (2002) Sphingosine kinases: a novel family of lipid kinases. Prog. Nucleic Acid Res. Mol. Biol. 71, 493–511.
van Helvoort, A., van't Hof, W., Ritsema, T., Sandra, A., and van Meer, G. (1994) Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby canine kidney) cells. Evidence for the reverse action of a sphingomyelin synthase. J. Biol. Chem. 269, 1763–1769.
Ruvolo, P. P. (2001) Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia 15, 1153–1160.
Lester, R. L., Wells, G. B., Oxford, G., and Dickson, R. C. (1993) Mutant strains of Saccharomyces cerevisiae lacking sphingolipids synthesize novel inositol glycerophospholipids that mimic sphingolipid structures. J. Biol. Chem. 268, 845–856.
Hanada, K., Nishijima, M., Kiso, M., Hasegawa, A., Fujita, S., Ogawa, T., et al. (1992) Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis by exogenous sphingolipids. J. Biol. Chem. 267, 23527–23533.
Dawkins, J. L., Hulme, D. J., Brahmbhatt, S. B., Auer-Grumbach, M., and Nicholson, G. A. (2001) Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type 1. Nat. Genetics 27, 309–312.
Bejaoui, K., Wu, C., Scheffler, M. D., Haan, G., Ashby, P., Wu, L., et al. (2001) SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat. Genetics, 27, 261–262.
Dawkins, J., Brahmbhatt, S., Auer-Grumbach, M., Wagner, K., Hartung, H., Verhoeven, K., et al. (2002) Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathy. Neuromuscul. Disord. 12, 656.
Jin, H. K., Carter, J. E., Huntley, G. W., and Schuchman, E. H. (2002) Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. J. Clin. Invest. 109, 1183–1191.
Rethy, L. A., Kalmanchey, R., Klujber, V., Koos, R., and Fekete, G. (2000) Acid sphingomyelinase deficiency in Beckwith Wiedemann syndrome. Pathol. Oncol. Res. 6, 295–297.
Merrill, A. H., Jr. and Sweeley, C. C. Sphingolipid metabolism and cell signaling. In: Biochemistry of Lipids, Lipoproteins, and Membranes. (Vance, D. E., and Vance, J., eds.) Elsevier Science, Amsterdam, 1996, pp. 309–338.
Spiegel, S., Cuvillier, O., Edsall, L. C., Kohama, T., Menzeleev, R., Olah, Z., et al. (1998) Sphingosine-1-phosphate in cell growth and cell death. Ann. NY Acad. Sci., 845, 11–18.
Spiegel, S., Cuvillier, O., Edsall, L., Kohama, T., Menzeleev, R., Olivera, A., et al. (1998) Roles of sphingosine-1-phosphate in cell growth, differentiation, and death. Biochemistry (Mosc) 63, 69–73.
Pyne, S., Chapman, J., Steele, L., and Pyne, N. J. (1996) Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle. Eur. J. Biochem. 237, 819–826.
Zhang, H., Desai, N. N., Olivera, A., Seki, T., Brooker, G., and Spiegel, S. (1991) Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 114, 155–167.
Gomez-Munoz, A., Waggoner, D. W., O'Brien, L., and Brindley, D. N. (1995) Interaction of ceramides, sphingosine, and sphingosine-1-phosphate in regulating DNA synthesis and phospholipase D activity. J. Biol. Chem. 270, 26318–26325.
Bornfeldt, K. E., Graves, L. M., Raines, E. W., Igarashi, Y., Wayman, G., Yamamura, S., et al. (1995) Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J. Cell Biol. 130, 193–206.
An, S., Zheng, Y., and Bleu, T. (2000) Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G proteincoupled receptors Edg3 and Edg5. J. Biol. Chem. 275, 288–296.
Pyne, S. and Pyne, N. J. (2002) Sphingosine 1-phosphate signalling and termination at lipid phosphate receptors. Biochim. Biophys. Acta 1582, 121–131.
Peyssonnaux, C. and Eychene, A. (2001) The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell 93, 53–62.
Yang, J., Yu, Y. N., and Duerksen-Hughes, P. J. (2003) Protein kinases and their involvement in the cellular responses to genotoxic stress. Rev. Mutat. Res. 543, 31–58.
Van Brocklyn, J. R., Lee, M. J., Menzeleev, R., Olivera, A., Edsall, L., Cuvillier, O., et al. (1998) Dual actions of sphingosine-1-phosphate: extracellular through the Gicoupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell. Biol. 142, 229–240.
Hanafusa, N., Yatomi, Y., Yamada, K., Hori, Y., Nangaku, M., Okuda, T., et al. (2002) Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells. Nephrol. Dial. Transplant 17, 580–586.
Olivera, A., Kohama, T., Edsall, L., Nava, V., Cuvillier, O., Poulton, S. et al. (1999) Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J. Cell. Biol. 147, 545–558.
Sawai, H., Okazaki, T., and Domae, N. (2002) Sphingosine-induced c-jun expression: differences between sphingosine- and C2-ceramide-mediated signaling pathways. FEBS Lett. 524, 103–106.
Ahn, E. H. and Schroeder, J. J. (2002) Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells. Exp. Biol. Med. 227, 345–353.
Chang, H. C., Tsai, L. H., Chuang, L. Y., and Hung, W. C. (2001) Role of AKT kinase in sphingosine-induced apoptosis in human hepatoma cells. J. Cell. Physiol. 188, 188–193.
Itakura, A., Tanaka, A., Aioi, A., Tonogaito, H., and Matsuda, H. (2002) Ceramide and sphingosine rapidly induce apoptosis of murine mast cells supported by interleukin-3 and stem cell factor. Exp. Hematol. 30, 272–278.
Kagedal, K., Zhao, M., Svensson, I., and Brunk, U. T. (2001) Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 359, 335–343.
Nava, V. E., Cuvillier, O., Edsall, L. C., Kimura, K., Milstien, S., Gelmann, E. P., et al. (2000) Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res. 60, 4468–4474.
Cuvillier, O., Edsall, L., and Spiegel, S. (2000) Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J. Biol. Chem. 275, 15691–15700.
Matsubara, S. and Ozawa, M. (2001) Expression of alpha-catenin in alphacatenin-deficient cells increases resistance to sphingosine-induced apoptosis. J. Cell Biol. 154, 573–584.
Hung, W. C., Chang, H. C., and Chuang, L. Y. (1999) Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells. Biochem. J. 338, 161–166.
Voss, K. A., Howard, P. C., Riley, R. T., Sharma, R. P., Bucci, T. J. and Lorentzen, R. J. (2002) Carcinogenicity and mechanism of action of fumonisin B1: a mycotoxin produced by Fusarium moniliforme (=F. verticillioides). Cancer Detect. Prev. 26, 1–9.
Schmelz, E. M., Dombrink-Kurtzman, M. A., Roberts, P. C., Kozoutsumi, Y., Kawasaki, T., and Merrill, A. H., Jr. (1998) Induction of apoptosis by Fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Toxicol. Appl. Pharmacol. 148, 252–260.
Ciacci-Zanella, J. R., Merrill, A. H., Jr., Wang, E., and Jones, C. (1998) Characterization of cell-cycle arrest by Fumonisin B1 in CV-1 cells. Food Chem. Toxicol. 36, 791–804.
Yu, C. H., Lee, Y. M., Yun, Y. P., and Yoo, H. S. (2001) Differential effects of fumonisin B1 on cell death in cultured cells: the significance of the elevated sphinganine. Arch. Pharm. Res. 24, 136–143.
Kim, M. S., Lee, Y. M., Wang, T., and Schroeder, J. J. (2001) Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine-and calmodulin-dependent pathway. Toxicol. Appl. Pharmacol. 176, 118–126.
Delongchamp, R. R. and Young, J. F. (2001) Tissue sphinganine as a biomarker of fumonisin-induced apoptosis. Food Addit. Contam. 18, 255–261.
Wispriyono, B., Schmelz, E., Pelayo, H., Hanada, K., and Separovic, D. (2002) A role for the de novo sphingolipids in apoptosis of photosensitized cells. Exp. Cell Res. 279, 153–165.
Dbaibo, G. S., Pushkareva, M. Y., Jayadev, S., Schwarz, J. K., Horowitz, J. M., Obeid, L. M., and Hannun, Y. A. (1995) Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Pro. Natl. Acad. Sci. USA 92, 1347–1351.
Jayadev, S., Liu, B., Bielawska, A. E., Lee, J. Y., Nazaire, F., Pushkareva, M. Y., et al. (1995) Role for ceramide in cell cycle arrest. J. Biol. Chem. 270, 2047–2052.
Jarvis, W. D., Kolesnick, R. N., Fornari, F. A., Traylon, R. S., Gewirtz, D. A., and Grant, S. (1994) Induction of apototic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA 91, 73–77.
Martin, S. J., Newmeyer, D. D., Mathias, S., Farschon, D. M., Wang, H., Reed, J. C., et al. (1995) Cell-free reconstitution of Fas-, UN radiation-and ceramide-induced apotposis. EMBO J. 14, 5191–5200.
Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. (1993) Programmed cell death induced by ceramide. Science 259, 1769–1771.
Vento, R., Giuliano, M., Lauricella, M., Carabillo, M., Di Liberto, D., and Tesoriere, G. (1998) Induction of programmed cell death in human retinoblastoma Y79 cells by C2-ceramide. Mol. Cell. Biochem. 185, 7–15.
Pruschy, M., Resch, H., Shi, Y. Q., Aalame, N., Glanzmann, C., and Bodis, S. (1999) Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells. Br. J. Cancer 80, 693–698.
Craighead, M., Pole, J., and Waters, C. (2000) Caspases mediate C2-ceramideinduced apoptosis of the human oligodendroglial cell line, MO3.13. Neurosci. Lett. 278, 125–128.
Connor, C. E., Burrows, J., Hearps, A. C., Woods, G. M., Lowenthal, R. M., and Ragg, S. J. (2001) Cell cycle arrest of hematopoietic cell lines after treatment with ceramide is commonly associated with retinoblastoma activation. Cytometry 43, 164–169.
Poppe, M., Reimertz, C., Munstermann, G., Kogel, D., and Prehn, J. H. (2002) Ceramide-induced apoptosis of D283 medulloblastoma cells requires mitochondrial respiratory chain activity but occurs independently of caspases and is not sensitive to Bcl-xL overexpression. J. Neurochem. 82, 482–494.
Magnoni, C., Euclidi, E., Benassi, L., Bertazzoni, G., Cossarizza, A., Seidenari, S. et al. (2002) Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and ceramide generation in cultured normal human keratinocytes. Toxicol. in Vitro 16, 349–355.
Dallalio, G., North, M., Worden, B. D., and Means, R. T., Jr. (1999) Inhibition of human erythroid colony formation by ceramide. Exp. Hematol. 27, 1133–1138.
Birbes, H., Bawab, S. E., Obeid, L. M., and Hannun, Y. A. (2002) Mitochondria and ceramide: intertwined roles in regulation of apoptosis. Adv. Enzyme Regul. 42, 113–129.
Mimeault, M. (2002) New advances on structural and biological functions of ceramide in apoptotic/necrotic cell death and cancer. FEBS Lett 530, 9–16.
Kim, S. S., Chae, H. S., Bach, J. H., Lee, M. W., Kim, K. Y., Lee, W. B., et al. (2002) T53 mediates ceramide-induced apoptosis in SKN-SH cells. Oncogene 21, 2020–2028.
Tomassini, B. and Testi, R. (2002) Mitochondria as sensors of sphingolipids. Biochimie 84, 123–129.
Hearps, A. C., Burrows, J., Connor, C. E., Woods, G. M., Lowenthal, R. M., and Ragg, S. J. (2002) Mitochondrial cytochrome c release precedes transmembrane depolarisation and caspase-3 activation during ceramide-induced apoptosis of Jurkat T cells. Apoptosis 7, 387–394.
Jones, B. E., Lo, C. R., Srinivasan, A., Valentino, K. L., and Czaja, M. J. (1999) Ceramide induces caspase-independent apoptosis in rat hepatocytes sensitized by inhibition of RNA synthesis. Hepatology 30, 215–222.
von Haefen, C., Wieder, T., Gillissen, B., Starck, L., Graupner, V., Dorken, B., et al. (2002) Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene 21, 4009–4019.
Lee, J. Y., Leonhardt, L. G., and Obeid, L. M. (1998) Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M. Biochem. J. 334, 457–461.
Shi, Y. Q., Wuergler, F. E., Blattmann, H., and Crompton, N. E. (2001) Distinct apoptotic phenotypes induced by radiation and ceramide in both p53-wild-type and p53-mutated lymphoblastoid cells. Radiat. Environ. Biophys. 40, 301–308.
Willaime, S., Vanhoutte, P., Caboche, J., Lemaigre-Dubreuil, Y., Mariani, J., and Brugg, B. (2001) Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur. J. Neurosci. 13, 2037–2046.
Brenner, B., Koppenhoefer, U., Weinstock, C., Linderkamp, O., Lang, F., and Gulbins, E. (1997) Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J. Biol. Chem. 272, 22173–22181.
Jarvis, W. D., Fornari, F. A., Jr., Auer, K. L., Freemerman, A. J., Szabo, E., Birrer, M. J., et al. (1997) Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol. Pharmacol. 52, 935–947.
Buisson-Legendre, N., Bernard, P., Bobichon, H., Emonard, H., Schneider, C., Maquart, F. X., et al. (1999) Involvement of the 92-kDa gelatinase (matrix, metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth. Biochem. Biophys. Res. Commun. 260, 634–640.
Pettus, B. J., Chalfant, C. E., and Hannun, Y. A. (2002) Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585, 114–125.
Mathias, S., Dressler, K. A., and Kolesnick, R. N. (1991) Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 88, 10009–10013.
Yao, B., Zhang, Y., Delikat, S., Mathias, S., Basu, S., and Kolesnick, R. (1995) Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378, 307–310.
Zhang, Y., Yao, B., Delikat, S., Bayoumy, S., Lin, X. H., Basu, S., et al. (1997) Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89, 63–72.
Basu, S., Bayoumy, S., Zhang, Y., Lozano, J., and Kolesnick, R. (1998) BAD enables ceramide to signal apoptosis via Ras and Raf-1. J. Biol. Chem. 273, 30419–30426.
Huwiler, A., Brunner, J., Hummel, R., Vervoordeldonk, M., Stabel, S., van den Bosch, H., et al. (1996) Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc. Natl. Acad. Sci. USA 93, 6959–6963.
Muller, G., Storz, P., Bourteele, S., Doppler, H., Pfizenmaier, K., Mischak, H., et al. (1998) Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling. EMBO J. 17, 732–742.
Muller, G., Ayoub, M., Storz, P., Rennecke, J., Fabbro, D., and Pfizenmaier, K. (1995) PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14, 1961–1969.
Berra, E., Diaz-Meco, M. T., Lozano, J., Frutos, S., Municio, M. M., Sanchez, P., et al. (1995) Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta. EMBO J. 14, 6157–6163.
Diaz-Meco, M. T., Lozano, J., Municio, M. M., Berra, E., Frutos, S., Sanz, L., et al. (1994) Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J. Biol. Chem. 269, 31706–31710.
Wickel, M., Heinrich, M., Weber, T., Brunner, J., Kronke, M., and Schutze, S. (1999) Identification of intracellular ceramide target proteins by affinity chromatography and TID-ceramide photoaffinity labelling. Biochem. Soc. Trans. 27, 393–399.
Heinrich, M., Wickel, M., Winoto-Morbach, S., Schneider-Brachert, W., Weber, T., Brunner, J., et al. (2000) Ceramide as an activator lipid of cathepsin D. Adv. Exp. Med. Biol. 477, 305–315.
Heinrich, M., Wickel, M., Schneider-Brachert, W., Sandberg, C., Gahr, J., Schwandner, R., et al. (1999) Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 18, 5252–5263.
Dobrowsky, R. T., Kamibayashi, C., Mumby, M. C., and Hannun, Y. A. (1993) Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268, 15523–15530.
Wolff, R. A., Dobrowsky, R. T., Bielawska, A., Obeid, L. M., and Hannun, Y. A. (1994) Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J. Biol. Chem. 269, 19605–19609.
Chalfant, C. E., Kishikawa, K., Mumby, M. C., Kamibayashi, C., Bielawska, A., and Hannun, Y. A. (1999) Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J. Biol. Chem. 274, 20313–20317.
Deng, X., Ito, T., Carr, B., Mumby, M., and May, W. S., Jr. (1998) Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A. J. Biol. Chem. 273, 34157–34163.
Ruvolo, P. P., Deng, X., Ito, T., Carr, B. K., and May, W. S. (1999) Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem. 274, 20296–20300.
Sato, S., Fujita, N., and Tsuruo, T. (2000) Modulation of Akt kinase activity by binding to Hsp90. Proc. Natl. Acad. Sci. USA 97, 10832–10837.
Sweeney, E. A., Inokuchi, J., and Igarashi, Y. (1998) Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide. FEBS Lett. 425, 61–65.
Moore, A. N., Kampfl, A. W., Zhao, X., Hayes, R. L., and Dash, P. K. (1999) Sphingosine-1-phosphate induces apoptosis of cultured hippocampal neurons that requires protein phosphatases and activator protein-1 complexes. Neuroscience 94, 405–415.
Gennero, I., Fauvel, J., Nieto, M., Cariven, C., Gaits, F., Briand-Mesange, F., et al. (2002) Apoptotic effect of sphingosine 1-phosphate and increased sphingosine 1-phosphate hydrolysis on mesangial cells cultured at low cell density. J. Biol. Chem. 277, 12724–12734.
Pyne, S. (2002) Cellular signaling by sphingosine and sphingosine 1-phosphate. Their opposing roles in apoptosis. Subcell. Biochem. 36, 245–268.
Cuvillier, O., Rosenthal, D. S., Smulson, M. E., and Spiegel, S. (1998) Sphingosine 1-phosphate inhibits activation of caspases that cleave phly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymhocytes. J. Biol. Chem. 273, 2910–2916.
Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S., et al. (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800–803.
Castillo, S. S. and Teegarden, D. (2001) Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells. J. Nutr. 131, 2826–2830.
Morita, Y., Perez, G. I., Paris, F., Miranda, S. R., Ehleiter, D., Haimovitz-Friedman, A., et al. (2000) Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med. 6, 1109–1114.
Manggau, M., Kim, D. S., Ruwisch, L., Vogler, R., Korting, H. C., Schafer-Korting, M., et al. (2001) 1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J. Invest. Dermatol. 117, 1241–1249.
Misasi, R., Sorice, M., Di Marzio, L., Campana, W. M., Molinari, S., Cifone, M. G., et al. (2001) Prosaposin treatment induces PC12 entry in the S phase of the cell cycle and prevents apoptosis: activation of ERKs and sphingosine kinase. FASEB J. 15, 467–474.
Cuvillier, O. and Levade, T. (2001) Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood 98, 2828–2836.
Kwon, Y. G., Min, J. K., Kim, K. M., Lee, D. J., Billiar, T. R., and Kim, Y. M. (2001) Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J. Biol. Chem. 276, 10627–10633.
Xia, P., Wang, L., Gamble, J. R., and Vadas, M. A. (1999) Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J. Biol. Chem. 274, 34499–34505.
Edsall, L. C., Cuvillier, O., Twitty, S., Spiegel, S., and Milstien, S. (2001) Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J. Neurochem. 76, 1573–1584.
Strelow, A., Bernardo, K., Adam-Klages, S., Linke, T., Sandhoff, K., kronke, M., et al. (2000) Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J. Exp. Med. 192, 601–612.
Prieschl, E. E., Csonga, R., Novotny, V., Kikuchi, G. E., and Baumruker, T. (1999) The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering. J. Exp. Med. 190, 1–8.
Le Stunff, H., Galve-Roperh, I., Peterson, C., Milstien, S., and Spiegel, S. (2002) Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J. Cell Biol. 158, 1039–1049.
Le Stunff, H., Peterson, C., Liu, H., Milstien, S., and Spiegel, S. (2002) Sphingosine-1-phosphate and lipid phosphohydrolases. Biochim. Biophys. Acta 1582, 8–17.
Baumruker, T. and Prieschl, E. E. (2002) Sphingolipids and the regulation of the immune response. Semin. Immunol. 14, 57–63.
Preschl, E. E. and Baumruker, T. (2000) Beyond a structural component: sphingolipids in immunology. Arch. Immunol. Ther. Exp. (Warsz) 48, 163–171.
Ballou, L. R. Geramide and inflammation. In: Sphingolipid-mediated signal transduction. (Hannun, Y. A., ed), R. G. Landes Company, Austin, Texas, 1997.
Goldsby, R. A., Kindt, T. J., and Osborne, B. A. Kuby Immunology. W. H. Freeman and Company, New York, 2000.
Dinarello, C. A. (1994) Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune disease. Curr. Opin. Immunol. 3, 941–948.
Dinarello, C. A. (1996) Biologic basis for interleukin-1 in disease. Blood 87, 2095–2147.
Dinarello, C. A. (1998) Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 16, 457–499.
Goetzl, E. J., An, S., and Smith, W. L. (1995) Specificity of expression and effects of eicosanoids mediators in normal physiology and human diseases. FASEB J. 9, 1051–1058.
Dbaibo, G. S., Obeid, L. M., and Hannun, Y. A. (1993) Tumor necrosis factor-alpha signal transduction through ceramide. J. Biol. Chem. 268, 17762–17766.
Kolesnick, R. and Golde, D. W. (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77, 325–328.
Nikolova-Karakashian, M., Morgan, E. T., Alexander, C., Liotta, D. C., and Merrill, A. H., Jr. (1997) Bimodal regulation of ceramidase by interleukin-1b: implications for the regulation of cytochrome p450 2C11. J. Biol. Chem. 272, 18718–18724.
Yamamura, S., Sadahira, Y., Ruan, F., Hakomori, S., and Igarashi, Y. (1996) Sphingosine-1-phosphate inhibits actin nucleation and pseudopodium formation to control cell motility of mouse melanoma cells. FEBS Lett. 382, 193–197.
Spiegel, S., Olivera, A., Zhang, H., Thompson, E. W., Su, Y., and Berger, A. (1994) Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells. Breast Cancer Res. Treat. 31, 337–348.
Takuwa, Y., Takuwa, N., and Sugimoto, N. (2002) The edg family g proteincoupled receptors for lysophospholipids: their signaling properties and biological activities. J. Biochem. (Tokyo) 131, 767–771.
Goetzl, E. J., Dolezalova, H., Kong, Y., Hu, Y. L., Jaffe, R. B., Kalli, K. R., et al. (1999) Distinctive expression and functions of the type 4 endothelial differentiation geneencoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res. 59, 5370–5375.
Stam, J. C., Michiels, F., van der Kammen, R. A., Moolenaar, W. H., and Collard, J. G. (1998) Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling. EMBO J. 17, 4066–4074.
Wargovich, M. J. (1997) Experimental evidence for cancer preventive elements in foods. Cancer Lett. 114, 11–17.
Potter, J. D. (1996) Nutrition and colorectal cancer. Cancer Causes Control 7, 127–146.
Kim, Y. I. and Mason, J. B. (1996) Nutrition chemoprevention of gastrointestinal cancers: a critical review. Nutr. Rev. 54, 259–279.
Mason, J. B. and Kim, Y. (1999) Nutritional strategies in the prevention of colorectal cancer. Curr. Gastroenterol. Rep. 1, 341–353
Schmelz, E. M., Crall, K. J., LaRocque, R., Dillehay, D. L., and Merrill, A. H. (1994) Uptake and metabolism of sphingolipids in isolated intestinal loops of mice. J. Nutr. 124, 701–712.
Schmelz, E. M., Dillehay, D. L., Webb, S. K., Reiter, A., Adams, J., and Merrill, A. H., Jr. (1996) Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcingoenesis. Cancer Res. 56, 4936–4941.
Birt, D. F., Merrill, A. H., Jr., Barnett, T., Enkvetchakul, B., Pour, P. M., Liotta, D. C., et al. (1998) Inhibition of skin carcinomas but not papillomas by sphingosine, N-methylsphingosine, and Nacetylsphingosine. Nutr Cancer 31, 119–126.
Venable, M. E. and Obeid, L. M. (1999) Phospholipase D in cellular senescence. Biochim. Biophys. Acta 1439, 291–298.
Obeid, L. M. and Venable, M. E. (1997) Signal transduction in cellular senescence. J. Am. Geriatr. Soc. 45, 361–366.
Yechiel, E. and Barenholz, Y. (1985) Relationships between membrane lipid composition and biological properties of rat myocytes. J. Biol. Chem. 260, 9123–9131.
Miller, C. J. and Stein, G. H. (2001) Human diploid fibroblasts that undergo a senescent-like differentiation have elevated ceramide and diacylglycerol. J. Gerontol. (A) Biol. Sci. Med. Sci. 56, B8–19.
Venable, M. E., Lee, J. Y., Smyth, M. J., Bielawska, A., and Obeid, L. M. (1995) Role of ceramide in cellular senescence. J. Biol. Chem. 270, 30701–30708.
Mouton, R. E. and Venable, M. E. (2000) Ceramide induces expression of the senescence histochemical marker, beta-galactosidase, in human fibroblasts. Mech. Ageing Dev. 113, 169–181.
Abousalham, A., Liossis, C., O'Brien, L., and Brindley, D. N. (1997) Cell permeable ceramides prevent the activation of phospholipase D by ADP ribosylation factor and RhoA. J. Biol. Chem. 272, 1069–1075.
Nakamura, Y., Nakashima, S., Ojio, K., Banno, Y., Miyata, H., and Nozawa, Y. (1996) Ceramide inhibits IgE-mediated activation of phospholipase D, but not of phospholipase C, in rat basophilic leukemia (RBL-2H3) cells. J. Immunol. 156, 256–262.
Yoshimura, S., Sakai, H., Ohguchi, K., Nakashima, S., Banno, Y., Nishimura, Y., et al. (1997) Changes in the activity and mRNA levels of phospholipase D during ceramide-induced apoptosis in rat C6 glial cells. J. Neurochem. 69, 713–720.
Tilly, J. L. and Kolesnick, R. N. (1999) Sphingolipid signaling in gonadal development and function. Chem. Phys. Lipids 102, 149–155.
Ghosh, S., Strum, J. C., and Bell, R. M. (1997) Lipid biochemistry: functions of glycerolipids and sphingolipids in cellular signaling. FASEB J. 11, 45–50.
Strum, J. C., Swenson, K. I., and Bell, R. M. A role for ceramide in meiosis. In: Sphingolipid-Mediated Signal Transduction. (Hannun, Y. A., ed.), R. G. Landes Company, Austin, Texas, 1997, pp. 53–60.
Morrill, G. A. and Kostellow, A. B. (1998) Progesterone release of lipid second messengers at the amphibian oocyte plasma membrane: role of ceramide in initiating the G2/M transition. Biochem. Biophys. Res. Commun. 246, 359–363.
Varnold, R. L. and Smith, L. D. (1990) Protein kinase C and progesterone-induced maturation in Xenopus oocytes. Development 109, 597–604.
Strum, J. C., Swenson, K. I., Turner, J. E., and Bell, R. M. (1995) Ceramide triggers meiotic cell cycle progression in Xenopus oocytes: a potential mediator of progesterone-induced maturation. J. Biol. Chem. 270, 13541–13547.
De Smedt, V., Rime, H., Jessus, C., and Ozon, R. (1995) Inhibition of glycoaphingolipid synthesis induces p34cdc2 activation in Xenopus oocyte. FEBS Lett. 375, 249–253.
Lin, T. Y., Viswanathan, S., Wood, C., Wilson, P. G., Wolf, N., and Fuller, M. T. (1996) Coordinate developmental control of the meiotic cell cycle and spermatid differentiation in Drosophila males. Development 122, 1331–1341.
Endo, K., Akiyama, T., Kobayashi, S., and Okada, M. (1996) Degenerative spermatocyte, a novel gene encoding a transmembrane protein required for the initiation of meiosis in Drosophila spermatogenesis. Mol. Gen. Genet. 253, 157–165.
Endo, K., Matsuda, Y., and Kobayashi, S. (1997) Mdes, a mouse homolog of the Drosophila degenerative spermatocyte gene is expressed during mouse spermatogenesis. Dev. Growth Differ. 39, 399–403.
Bielawska, A., Crane, H. M., Liotta, D., Obeid, L. M., and Hannun, Y. A. (1993) Selectivity of ceramide-mediated biology. Lack of activity of erythrodihydroceramide. J. Biol. Chem. 268, 26226–26232.
Michel, C., van Echten-Deckert, G., Rother, J., Sandhoff, K., Wang, E., and Merrill, A. H., Jr., (1997) Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J. Biol. Chem. 272, 22432–22437.
Sax, C. M. and Piatigorsky, J. (1994) Expression of the alpha-crystallin/small heat-shock protein/molecular chaperone genes in the lens and other tissues. Adv. Enzymol. Relat. Areas Mol. Biol. 69, 155–201.
Shyman, J. A. and Radin, N. S. The use of cerebroside synthase inhibitors as probes for assessing the metabolism and function of sphingolipids. In: Sphingolipid-Mediated Signal Transduction. (Hannun, Y. A., ed.), R. G. Landes Company, Austin, Texas, 1997, pp. 91–102.
Chang, Y., Abe, A., and Shayman, J. A. (1995) Ceramide formation during heat shock: a potential mediator of alpha B-crystallin transcription. Proc. Natl. Acad. Sci. USA, 92, 12275–12279.
Ferguson-Yankey, S. R., Skrzypek, M. S., Lester, R. L., and Dickson, R. C. (2002) Mutant analysis reveals complex regulation of sphin-golipid long chain base phosphates and long chain bases during heat stress in yeast. Yeast 19, 573–586.
Skrzypek, M. S., Nagiec, M. M., Lester, R. L., and Dickson, R. C. (1999) Analysis of phosphorylated sphingolipid long-chain bases reveals potential roles in heat stress and growth control in Saccharomyces. J. Bacteriol. 181, 1134–1140.
Jenkins, G. M., Richards, A., Wahl, T., Mao, C., Obeid, L., and Hannun, Y. (1997) Involvement of yeast sphingolipids in the heat stress response of Saccharomyces cerevisiae. J. Biol. Chem. 272, 32566–32572.
Dickson, R. C., Nagiec, E. E., Skrzypek, M., Tillman, P., Wells, G. B., and Lester, R. L. (1997) Sphingolipids are potential heat stress signals in Saccharomyces. J. Biol. Chem. 272, 30196–30200.
Wells, G. B., Dickson, R. C. and Lester, R. L. (1998) Heat-induced elevation of ceramide in Saccharomyces cerevisiae via de novo synthesis. J. Biol. Chem. 273, 7235–7243.
Jenkins, G. M., Cowart, L. A., Signorelli, P., Pettus, B. J., Chalfant, C. E., and Hannun, Y. A. (2002) Acute activation of de novo sphin-golipid biosynthesis upon heat shock causes an accumulation of ceramide and subsequent dephosphorylation of SR proteins. J. Biol. Chem. 277, 42572–42578.
Kondo, T., Matsuda, T., Kitano, T., Takahashi, A., Tashima, M., Ishikura, H., et al. (2000) Role of c-jun expression increased by heat shock-and ceramide-activated caspase-3 in HL-60 cell apoptosis. Possible involvement of ceramide in heat shock-induced apoptosis. J. Biol. Chem. 275, 7668–7676.
Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., et al. (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380, 75–79.
Huang, C., Ma, W., Ding, M., Bowden, G. T., and Dong, Z. (1997) Direct evidence for an important role of sphingomyelinase in ultraviolet-induced activation of c-Jun N-terminal kinase. J. Biol. Chem. 272, 27753–27757.
Grether-Beck, S., Bonizzi, G., Schmitt-Brenden, H., Felsner, I., Timmer, A., Sies, H., et al. (2000) Non-enzymatic triggering of the ceramide signalling cascade by solar UVA radiation, EMBO J. 19, 5793–5800.
Chatterjee, M. and Wu, S. (2001) Cell line dependent involvement of ceramide in ultraviolet light-induced apoptosis. Mol. Cell. Biochem. 219, 21–27.
Holleran, W. M., Uchida, Y., Halkier-Sorensen, L., Haratake, A., Hara, M., Epstein, J., et al. (1997) Structural basis for the UVB-induced abnormality in epidermal barrier function. Photodermatol. Photoimmunol. Photomed. 13, 117–128.
Farrell, A. M., Uchida, Y., Nagie, M. M., Harris, I. R., Dickson, R. C., Elias, P. M., et al. (1998) UVB irradiation up-regulates serine palmitoyltransferase in cultured human keratinocytes. J. Lipids Res. 39, 2031–2038.
Deng, J., Zhang, H., Kloosterboer, F., Liao, Y., Klostergaard, J., Levitt, M. L., et al. (2002) Ceramide does not act as a general second messenger for ultraviolet-induced apoptosis. Oncogene 21, 44–52.
Verheij, M., van Blitterswijk, W. J., and Bartelink, H. (1998) Radiation-induced apoptosis—the ceramide-SAPK signaling pathway and clinical aspects. Acta Oncol. 37, 575–581.
Watters, D. (1999) Molecular mechanisms of ionizing radiation-induced apoptosis. Immunol. Cell. Biol. 77, 263–271.
Schmidt-Ullrich, R. K., Dent, P., Grant, S., Mikkelsen, R. B., and Valerie, K. (2000) Signal transduction and cellular radiation responses. Radiat. Res. 153, 245–257.
Haimovitz-Friedman, A., Kolesnick, R. N., and Fuks, Z. (1997) Differential inhibition of radiation-induced apoptosis. Stem Cells 15, 43–47.
Haimovitz-Friedman, A., Kan, C. C., Ehleiter, D., Persanud, R. S., McLoughlin, M., Fuks, Z., et al. (1994) Ionizing radiation acts on cellular membranes to generate ceramid and initiate apoptosis. J. Exp. Med. 180, 525–535.
Fuks, Z., Haimovitz-Friedman, A., and Kolesnick, R. N. (1995) The role of the sphingomyelin pathway in radiation-induced cell kill. Important Adv. Oncol. 9, 19–31.
Michael, J. M., Lavin, M. F., and Watters, D. J. (1997) Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 57, 3600–3605.
Chmura, S. J., Mauceri, H. J., Advani, S., Heimann, R., Beckett, M. A., Nodzenski, E., et al. (1997) Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation. Cancer Res. 57, 4340–4347.
Santana, P., Pena, L. A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., et al. (1996) Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86, 189–199.
Bruno, A. P., Laurent, G., Averbeck, D., Demur, C., Bonnet, J., Bettaieb, A., et al. (1998) Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Differ. 5, 172–182.
Chmura, S. J., Nodzenski, E., Kharbanda, S., Pandey P., Quintans, J., Kufe, D. W. et al. (2000) Down-regulation of ceramide production abrogates ionizing radiation-induced cytochrome c release and apoptosis. Mol. Pharmacol. 57, 792–796.
Grant, S. (1997) 1-[b-D-arabinofuranosyl]cytosine: molecular and cellular pharmacology. Adv. Cancer Res. 72, 197–233.
Mayer, R. J., Davis, R. B., Schiffer, C. A., Berg, D. T., Powell, B. L., Schulman, P., et al. (1994) Intensive postremisson chemotherapy in adults with acute myeloid leukemia. Cancer and leukemia group B. New Engl. J. Med. 331, 896–903.
Gunji, H., Kharbanda, S., and Kufe, D. (1991) Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-darabinofuranosylcytosine. Cancer Res. 51, 741–743.
Kufe, D., Spriggs, D., Egan, E. M., and Munroe, D. (1984) Relationships among Ara-CTP pools, formation of (Ara-C) DNA, and cytotoxicity of human leukemic cells. Blood 64, 54–58.
Strum, J. C., Small, G. W., Pautig, S. B., and Daniel, L. W. (1994) 1-beta-d- arabinofuranosylcytosine stimulates ceramides and diglyceride formation in HL-60 cells. J. Biol. Chem. 269, 15493–15497.
Grant, S., Freemerman, A. J., Birrer, M. J., Martin, H. A., Turner, A. J., Szabo, E., et al. (1996) Effect of 1-[b-D-arabinofuranosyl]cytosine on apoptosis and differentiation in human monoblastic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM-67). Cell Death Differ. 7, 603–613.
Hande, K. R. (1998) Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim. Biophys. Acta 1400, 173–184.
Jaffrezou, J.-P., Levade, T., Bettaieb, A., Andrieu, N., Bezombes, C., Maestre, N., et al., (1996). Daunorubicin-induced apoptosis: triggering ceramide generation through sphingomyelin hydrolysis. EMBO J. 15, 2417–2424.
Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., and Kolesnick, R. N. (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell Death Differ. 82, 405–414.
Allouche, M., Bettaieb, A., Vindis, C., Rousse, A., Gringon, C., and Laurent, G. (1997) Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells. Oncogene 14, 1837–1845.
Mansat, V., Bettaieb, A., Levade, T., Laurent, G., and Jaffrezou, J. P. (1997) Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. FASEB J. 11, 695–702.
Mansat, V., Laurent, G., Levade, T., Bettaieb, A., and Jaffrezou, J. P. (1997) The protein kinase C activators phorbol diesters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res. 57, 5300–5304.
Hande, K. R. (1998) Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer 34, 1514–1521.
Tepper, A. D., de Vries, E., van Blitterswijk, W. J., and Borst, J. (1999) Ordering of ceremide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis. J. Clin. Invest. 103, 971–978.
Perry, D. K., Carton, J., Shah, A. K., Meredith, F., Uhlinger, D. J., and Hannun, Y. A. (2000) Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem. 275, 9078–9084.
Duerksen-Hughes, P., Yang, J., and Schwartz S. B. (1999) HPV16E6 blocks TNF-mediated apoptosis in mouse fibroblast LM cells. Virology 264, 55–65.
Nikolova-Karakashian, M., Vales, T. R., Wang, E., Menaldino, D. S., Alexander, C., Goh, J., et al. Ceramide synthase and ceramidases in the regulation of sphingoid base metabolism. In: Sphingolipid-Mediated Signal Transduction. (Hannun, Y. A., ed.), R. G. Landes Company, Austin, Texas, 1997, pp. 159–172.
Blazquez, C., Geelen, M. J., Velasco, G., and Guzman, M. (2001) The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett. 489, 149–153.
Mandala, S. M. and Harris, G. H. (2000) Isolaton and characterization of novel inhibitors of sphingolipid synthesis: australifungin, viridiofungins, rustmicin, and khafrefungin. Methods Enzymol. 311, 335–348.
Kiuchi, M., Adachi, K., Kohara, T., Minoguchi, M., Hanano, T., Aoki, Y., et al. (2000) Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols. J. Med. Chem. 43, 2946–2961.
Riely, R. T., Norred, W. P., Wang, E., and Merrill, A. H., Jr. (1999) Alteration in sphingolipid metabolism: bioassays for fumonisinand ISP-1-like activity in tissues cells and other matrices. Nat. Toxins 7, 407–414.
Linn, S. C., Kim, H. S., Keane, E. M., Andras, L. M., Wang, E., and Merrill, A. H., Jr. (2001) Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption. Biochem. Soc. Trans. 29, 831–835.
Merrill, A. H., Jr., Sullards, M. C., Wang, E., Voss, K. A., and Riely, R. T. (2001) Sphingolipid metabolism: roles in signal transduction and disruption by fumonisin. Environ. Health Perspect. 109, 283–289.
Merrill, A. H. J., Liotta, D. C., and Riley, R. T. (1996) Fumonisins: fungal toxins that shed light on sphingolipid function. Trends Cell Biol. 6, 218–223.
Humpf, H. U., Schmelz, E. M., Meredith, F. I., Vesper, H., Vales, T. R., Wang, E., et al. (1998) Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor. J. Biol. Chem. 273, 19060–19064.
Desai, K., Sullards, M. C., Allegood, J., Wang, E., Schmelz, E. M., Hartl, M., et al. (2002) Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis. Biochim. Biophys. Acta 1585, 188–192.
Riely, R. T., Enongene, E., Voss, K. A., Norred, W. P., Meredith, F. I., Sharma, R. P., et al. (2001) Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect. 109, 301–308.
Abne, C. C., Borkowf, C. B., Qiao, Y. L., Albert, P. S., Wang, E., Merrill, A. H., Jr., et al. (2001) Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in China. Cancer Cause Control 12, 821–828.
Rani, C. S., Abe, A., Chang, Y., Rosenzweig, N., Saltiel, A. R., Radin, N. S. et al. (1995) Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases. J. Biol. Chem. 270, 2859–2867.
Shayman, J. A., Mahdiyoun, S., Deshmukh, G., Barcelon, F., Inokuchi, J., and Radin, N. S. (1990) Glucosphingolipid dependence of hormone-stimulated inositol trisphosphate formation. J. Biol. Chem. 265, 12135–12138.
Olshefski, R. and Ladisch S. (1998) Synthesis shedding, and intercellular transfer of human medulloblastoma gangliosides: abrogation by a new inhibitor of glucosylceramide synthase. J. Neurochem. 70, 467–472.
di Bartolomeo, S. and Spinedi, A. (2001) Differential chemosensitizing effect of two glucosylceramide: synthase inhibitors in hepatoma cells. Biochem. Biophys. Res. Commun. 288, 269–274.
Levade, T., Andrieu-Abadie, N., Segui, B., Auge, N., Chatelut, M., Jaffrezou, J. P., et al. (1999) Sphingomyelin-degrading pathways in human cells: role in cell signalling. Chem. Physics Lipids 102, 167–178.
Chatterjee, S. (1993) Neutral sphingomyelinase. Adv. Lipid Res. 26, 25–47.
Okazaki, T., Bielawska, A., Domane, N., Bell, R. M., and Hannun, Y. A. (1994) Characteristics and partial purification of a novel cytosolic, magnesium independent, neutral sphingomyelinase activated in the early signal transduction of 1a, 25-dihydorxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem. 269, 4070–4077.
Spence, M. W. (1993) Sphingomyelinases. Adv. Lipid Res. 26, 3–23.
Schmuth, M., Man, M. Q., Weber, F., Gao, W., Feingold, K. R., Fritsch, P., et al. (2000) Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J. Invest. Dermatol. 115, 459–466.
Hauck, C. R., Grassme, H., Bock, J., Jendrossek, V., Ferlinz, K., Meyer, T. F., et al. (2000) Acid sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of Neisseria gonorrhoeae. FEBS Lett. 478, 260–266.
Hurwitz, R., Ferlinz, K., and Sandhoff, K. (1994) The tricyclic antidepressant desipramine causes proteolytic degradation of lysosomal sphingomyelinase in human fibroblasts. Biol. Chem. Hoppe Seyler 375, 447–450.
Uchida, R., Tomoda, H., Arai, M., and Omura, S. (2001) Chlorogentisylquinone, a new neutral sphingomyelinase inhibitor, produced by a marine fungus. J. Antibiot. (Tokyo) 54, 882–889.
Nara, F., Tanaka, M., Masuda-Inoue, S., Yamasato, Y., Doi-Yoshioka, H., Suzuki-Konagai, et al. (1999) Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima. J. Antibiot. (Tokyo) 52, 531–535.
Arenz, C., Gartner, M., Wascholowski, V., and Giannis, A. (2001) Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase. Bioorg. Med. Chem. 9, 2901–2904.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, J., Yu, Y., Sun, S. et al. Ceramide and other sphingolipids in cellular responses. Cell Biochem Biophys 40, 323–350 (2004). https://doi.org/10.1385/CBB:40:3:323
Issue Date:
DOI: https://doi.org/10.1385/CBB:40:3:323